| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2005;46:719.)
© 2005 American Heart Association, Inc.
Original Articles |
From the Department of Cardiovascular Genome Science (J.X., K.O., M.Y.), Nagoya University School of Medicine, Japan; Department of Molecular Medicine and Clinical Science (J.X., T. Naoe), Department of Cardiology (H.I., T.M.), and Department of Clinical Pathophysiology (T. Nagasaka), Nagoya University Graduate School of Medicine, Japan; Nagoya University School of Health Sciences (K.N., A.N.), Japan; Life Science Research Center (S.I.), Mie University, Tsu, Japan; and Toyota Memorial Hospital (M.I.), Japan.
Correspondence to Mitsuhiro Yokota, MD, PhD, FAHA, FACC, Department of Cardiovascular Genome Science, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. E-mail myokota{at}med.nagoya-u.ac.jp
Long-term administration of vasodilators increases shear stress, which is thought to be important for vascular growth in the heart. Nicorandil, an activator of ATP-sensitive potassium channels with a nitrate-like action, is a potent vasodilator. We have now investigated the effects of nicorandil on vascular growth and gene expression in the failing heart of Dahl salt-sensitive (DS) hypertensive rats. DS rats fed a high-salt diet from 6 weeks of age develop concentric cardiac hypertrophy secondary to hypertension at 11 weeks, followed by heart failure at 18 weeks. DS rats on such a diet were treated with a nonantihypertensive oral dose of nicorandil (6 mg/kg per day) or vehicle from 11 to 18 weeks of age. Treatment of DS rats with nicorandil improved cardiac function and attenuated the development of heart failure. Myocardial capillary and arteriolar densities did not differ between vehicle-treated DS rats and age-matched controls. The abundance of mRNAs for endothelial NO synthase (eNOS), vascular endothelial growth factor (VEGF), the VEGF receptor Flt-1, and basic fibroblast growth factor (bFGF) in the myocardium was markedly reduced in vehicle-treated DS rats compared with controls. Treatment of DS rats with nicorandil greatly increased capillary and arteriolar densities and inhibited the downregulation of eNOS, VEGF, fms-like tyrosin kinase-1, and bFGF gene expression. This, nicorandil stimulates coronary capillary and arteriolar growth and thereby likely suppresses the development of heart failure in DS rats. Nicorandil may prove beneficial for the treatment of hypertensive heart failure as well as of ischemic heart disease.
Key Words: endothelial growth factors fibroblast growth factor potassium channels heart failure
Related Articles:
Hypertension 2006 47: e8.
Hypertension 2005 46: 647-648.
This article has been cited by other articles:
![]() |
C.-S. Kang, C.-C. Chen, C.-C. Lin, N.-C. Chang, and T.-M. Lee Effect of ATP-sensitive potassium channel agonists on sympathetic hyperinnervation in postinfarcted rat hearts Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1949 - H1959. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miyachi, H. Yazawa, M. Furukawa, K. Tsuboi, M. Ohtake, T. Nishizawa, K. Hashimoto, T. Yokoi, T. Kojima, T. Murate, et al. Exercise Training Alters Left Ventricular Geometry and Attenuates Heart Failure in Dahl Salt-Sensitive Hypertensive Rats Hypertension, April 1, 2009; 53(4): 701 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-M. Lee, M.-S. Lin, and N.-C. Chang Effect of ATP-Sensitive Potassium Channel Agonists on Ventricular Remodeling in Healed Rat Infarcts J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1309 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagata, K. Obata, J. Xu, S. Ichihara, A. Noda, H. Kimata, T. Kato, H. Izawa, T. Murohara, and M. Yokota Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Failure in Low-Aldosterone Hypertensive Rats Hypertension, April 1, 2006; 47(4): 656 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Barbato Nicorandil: The Drug That Keeps on Giving Hypertension, October 1, 2005; 46(4): 647 - 648. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |